Clinical trial
Active Surveillance for Adverse Events After Immunization With IXIARO(R) Among U.S. Military Service Personnel
NCT01335412 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Surveillance for Adverse Events After Immunization With IXIARO(R) Among U.S. Military Service Personnel
- Lead sponsor
- Valneva Austria GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- June 30, 2013
- Enrollment
- 20,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
japanese encephalitis